FindMyKOL
Clinical trialNCT05904236TerminatedPhase 1Interventional

Safety and Tolerability of Intravenous Administration of ICVB-1042

SponsorIconOVir BioEnrollment17Patients With Advanced Solid Tumors
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study to evaluate the safety and tolerability of intravenous ICVB-1042

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • California Cancer Associates

    San Marcos, California, United States

  • Karmanos Cancer Institute

    Detroit, Michigan, United States

  • Nyu Langone Health, Perlmutter Cancer Center

    New York, New York, United States

  • University of North Carolina Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

  • Carolina Biooncology

    Huntersville, North Carolina, United States

  • University of Pennsylvania, Abramson Cancer Center

    Philadelphia, Pennsylvania, United States

  • Sarah Cannon Research Institute

    Nashville, Tennessee, United States

  • Next Oncology, Dallas

    Irving, Texas, United States

  • Next Oncology, San Antonio

    San Antonio, Texas, United States

  • Next Oncology, Virginia

    Fairfax, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Treatment with ICVB-1042 administered intravenously
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jun 2023
Primary completion
11 Dec 2024
Completion
20 Dec 2024
Last update posted
8 Apr 2025
Registered enrollment
17
Registry id
NCT05904236

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.